Literature DB >> 8964032

Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

M Clementi1, S Menzo, P Bagnarelli, A Valenza, S Paolucci, R Sampaolesi, A Manzin, P E Varaldo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8964032      PMCID： PMC172887          DOI： 10.1128/CMR.9.2.135

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN： 0893-8512            Impact factor:   26.132


× No keyword cloud information.
  170 in total

1.  The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?

Authors:  S Jurriaans; B Van Gemen; G J Weverling; D Van Strijp; P Nara; R Coutinho; M Koot; H Schuitemaker; J Goudsmit
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

Review 2.  Competitive polymerase chain reaction and analysis of viral activity at the molecular level.

Authors:  M Clementi; P Bagnarelli; A Manzin; S Menzo
Journal:  Genet Anal Tech Appl       Date:  1994

3.  Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia.

Authors:  C J Miller; M Marthas; J Torten; N J Alexander; J P Moore; G F Doncel; A G Hendrickx
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: correlation between in vitro and in vivo events.

Authors:  R Schwiebert; P N Fultz
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.

Authors:  A Lafeuillade; C Tamalet; P Pellegrino; P de Micco; C Vignoli; R Quilichini
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-10

6.  Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression.

Authors:  L Chakrabarti; M C Cumont; L Montagnier; B Hurtrel
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA.

Authors:  H J Lin; L E Myers; B Yen-Lieberman; F B Hollinger; D Henrard; C J Hooper; R Kokka; S Kwok; S Rasheed; M Vahey
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

Review 8.  Markers predicting progression of human immunodeficiency virus-related disease.

Authors:  C M Tsoukas; N F Bernard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

9.  Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes.

Authors:  K Saksela; C Stevens; P Rubinstein; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Provirus copy number to predict disease progression in asymptomatic human immunodeficiency virus type 1 infection.

Authors:  S Chevret; M Kirstetter; M Mariotti; F Lefrère; J Frottier; J J Lefrère
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226
View more
  9 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Comparison of analytic methods for quantitative real-time polymerase chain reaction data.

Authors:  Ping Chen; Xuelin Huang
Journal:  J Comput Biol       Date:  2015-07-23       Impact factor: 1.479

3.  Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.

Authors:  F Damond; D Descamps; I Farfara; J N Telles; S Puyeo; P Campa; A Leprêtre; S Matheron; F Brun-Vezinet; F Simon
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

4.  Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.

Authors:  P Bagnarelli; A Valenza; S Menzo; R Sampaolesi; P E Varaldo; L Butini; M Montroni; C F Perno; S Aquaro; D Mathez; J Leibowitch; C Balotta; M Clementi
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay.

Authors:  P Gomes; N C Taveira; J M Pereira; F Antunes; M O Ferreira; M H Lourenço
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

6.  Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy.

Authors:  M Segondy; J Izopet; I Pellegrin; B Montes; B Dumon; C Pasquier; M Peeters; H J Fleury; J Puel; J Reynes
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

Review 7.  Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

Authors:  M Boeckh; G Boivin
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

Review 8.  Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system.

Authors:  Paola Cinque; Simona Bossolasco; Ake Lundkvist
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

9.  Factors associated with HIV-1 proviral DNA loads in patients with undetectable plasma RNA load.

Authors:  Jun Yong Choi; Young Goo Song; Young Hwa Kim; Chang Oh Kim; Myung Soo Kim; Bum Sik Chin; Sang Hoon Han; Suk Hoon Choi; Han Sung Lee; Su Jin Jeong; Heekyoung Choi; June Myung Kim
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.